Release Date: 30/03/12 09:09 Summary: Market update - SELM Proposal Price Sensitive: Yes Download Document 13.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%